Showing all 9 results
Anastrozole Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Cytotoxic Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the active API.
Active Ingredient Strength Primary Clinical Function Anastrozole USP/Ph.Eur. 1 mg The Standard Oncology Anchor: The globally validated dose for both adjuvant and first-line treatment of advanced breast cancer. Excipients Proprietary Matrix High-Containment Coating: Engineered with an impenetrable film-coat to prevent the release of cytotoxic dust, ensuring safety for healthcare workers. Bicalutamide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Cytotoxic Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the active API.
Active Ingredient Strength Primary Clinical Function Bicalutamide USP/Ph.Eur. 50 mg The Metastatic Anchor: Used in combination with a LHRH analogue (medical castration) for advanced metastatic disease. Bicalutamide USP/Ph.Eur. 150 mg The Monotherapy Payload: Utilized as a standalone treatment for locally advanced, non-metastatic prostate cancer. Excipients Proprietary Matrix High-Containment Coating: Engineered with an impenetrable film-coat to prevent the release of cytotoxic dust during handling by healthcare professionals. Capecitabine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Cytotoxic Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the active API.
Active Ingredient Strength Primary Clinical Function Capecitabine USP/Ph.Eur. 150 mg The Precision Titration Anchor: Utilized for accurate dose adjustments based on Body Surface Area (BSA). Capecitabine USP/Ph.Eur. 500 mg The Oncology Macrodose: The primary therapeutic unit for standard cycles in Colorectal and Breast cancer. Excipients Proprietary Matrix High-Containment Coating: Engineered with an impenetrable film-coat to prevent the release of cytotoxic dust during handling by healthcare professionals. Chlorambucil Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Low-Dose Cytotoxic Tablet, packed exclusively in light-shielded, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical survival of the sensitive aromatic mustard payload.
Active Ingredient Strength Primary Clinical Function Chlorambucil USP/Ph.Eur. 2 mg The Standard Hematology Anchor: The definitive unit utilized for chronic, daily maintenance and precise titration in CLL and low-grade lymphomas. Chlorambucil USP/Ph.Eur. 5 mg The Pulse-Dosing Payload: High-efficacy therapeutic payload utilized for “Pulse” therapy regimens or initial aggressive induction phases. Excipients Lactose Anhydrous / Colloidal Silicon Dioxide / Magnesium Stearate / Hypromellose / Titanium Dioxide / Premium Polymeric Film Diluent / Glidant / Lubricant / Protective Cytotoxic Shield (Engineered specifically utilizing an impenetrable film coat. This ensures the highly toxic, mutagenic API never comes into contact with the skin of the pharmacist or caregiver handling the medication). *Pack Sizes: 25-Tablet or 30-Tablet Bottles/Blisters (Optimized for oncology-specific treatment cycles).
Cyclophosphamide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Cytotoxic Prodrug Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical stability of the sensitive nitrogen mustard derivative and to physically protect caregivers from API exposure.
Active Ingredient Strength Primary Clinical Function Cyclophosphamide USP/Ph.Eur.
(as Cyclophosphamide Monohydrate)50 mg The Oncology & Autoimmune Macrodose: The definitive oral therapeutic unit utilized for chronic, daily continuous “metronomic” chemotherapy regimens and severe immunosuppressive maintenance. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Starch / Magnesium Stearate / Heavy Sucrose or Polymeric Film-Coat Diluent / Densifier / Disintegrant / Lubricant / Protective Cytotoxic Shield (Engineered specifically utilizing a thick, impenetrable sugar or film coat to ensure the highly toxic API never comes into contact with the skin of the patient, pharmacist, or caregiver handling the pill) *Pack Sizes: Bottles of 50/100 or 10×10 Alu-Alu Blisters (Optimized specifically for strict chronic oncology and rheumatology dispensing regimens).
Exemestane Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the potent steroidal antineoplastic agent.
Active Ingredient Strength Primary Clinical Function Exemestane USP/Ph.Eur. 25 mg Global Adult Oncology Standard: The definitive daily maintenance dose required to maintain absolute, continuous destruction of peripheral aromatase enzymes and keep estrogen levels crashed. Excipients Mannitol / Copovidone / Crospovidone / Sodium Starch Glycolate / Magnesium Stearate / Premium Polymeric Film Diluent / High-Shear Binder / Superdisintegrant / Surfactant / Heavy Film-Coating (Engineered specifically to lock the highly potent, teratogenic steroidal API safely inside the tablet, completely preventing handler and pharmacist exposure to the hazardous dust) *Pack Sizes: 10×10 Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic oncology dispensing regimens).
Letrozole tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the micro-dosed endocrine disruptor.
Active Ingredient Strength Primary Clinical Function Letrozole USP/Ph.Eur. 2.5 mg Global Oncology & Fertility Standard: The universal therapeutic unit utilized for 5-to-10 year daily adjuvant breast cancer therapy, or short 5-day cyclic dosing for ovulation induction. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Sodium Starch Glycolate / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Opadry Film Diluent / Binder / Superdisintegrant / Glidant / Slipper-Coating (Engineered specifically using elite geometric dilution to ensure the microscopic 2.5mg active payload is flawlessly distributed throughout the tablet, guaranteeing absolute content uniformity) *Pack Sizes: 10×10 Blisters or Bottles of 30 (Optimized specifically for strict, heavily monitored chronic oncology dispensing or monthly fertility cycles).
Morphine Sulphate SR Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Extended-Release Matrix Tablet, packed exclusively in highly secure, tamper-evident Alu-PVC or Alu-Alu blister strips to ensure the absolute physical stability of the controlled-release polymers.
Active Ingredient Strength Primary Clinical Function Morphine Sulphate USP/Ph.Eur. 15 mg (SR) Initiation / Titration Standard: Base therapeutic unit for opioid-naïve patients starting around-the-clock chronic pain management. Morphine Sulphate USP/Ph.Eur. 30 mg / 60 mg (SR) Global Oncology Standard: High-dose adult maintenance therapy for severe, opioid-tolerant terminal cancer and intractable neuropathic pain. Excipients Hypromellose (HPMC) / Cetostearyl Alcohol / Lactose Monohydrate / Magnesium Stearate / Premium Color-Coded Film Hydrophilic Polymer / Lipophilic Retardant / Diluent / Lubricant (Engineered specifically to form an impenetrable, slow-eroding gel matrix in the GI tract, strictly metering the release of the narcotic over 12 hours) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 30-day chronic oncology dispensing regimens; frequently color-coded by strength to prevent fatal dispensing errors).
Pazopanib Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered, High-Density Film-Coated Tablet, packed exclusively in highly secure, child-resistant heavy-gauge HDPE bottles or specialized Alu-Alu blister strips to ensure the absolute chemical stability of the cytotoxic molecule and prevent accidental exposure.
Active Ingredient Strength Primary Clinical Function Pazopanib HCl INN/Ph.Eur. 200 mg (Base Equivalent) Dose-Modification Standard: Essential unit for precise dose reduction in patients experiencing severe hepatic toxicity or adverse drug reactions. Pazopanib HCl INN/Ph.Eur. 400 mg (Base Equivalent) Global Clinical Standard: Primary therapeutic unit designed to achieve the massive 800 mg daily protocol with minimal pill burden. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone K30 / Magnesium Stearate / Hypromellose / Titanium Dioxide Diluent / Superdisintegrant / Binder / Lubricant / Premium Cytotoxic-Barrier Film-Coating (Engineered specifically to seal the lethal HPAPI inside the tablet, completely protecting healthcare workers and caregivers from highly toxic dust exposure) *Pack Sizes: Bottles of 30 or 60 Tablets (Optimized specifically for strict 30-day chronic oncology dispensing regimens).
